General Information

• Abstracts must be submitted and presented in English
• You should only submit work if you, or a designee, are committed to registering for and attending the Congress to give your Oral or E-Poster presentation
• Registration is not mandatory in the submission process; however, all Presenting Authors must register for the Congress deadline by June 27, 2025, otherwise, the abstract will not be included in the final Congress program
• There is no limit to the number of abstracts you may submit, however, the Abstract Selection Committee aims to achieve a wide geographic spread of presenters
• There are 2 presentation types: Oral and E-Poster. You may indicate your preference, but the Abstract Selection Committee will make the final format determination
• Abstracts cannot contain advertising, trade names, or product group messages. Please use generic names or terms in your abstract content

Information Required to Complete a Submission

Submitting Author: The author that submits the abstract, to whom all correspondence will be addressed and sent. The Submitting Author is assumed to be the Presenting Author unless otherwise indicated

• Title (maximum 20 words)
• Keywords (maximum 4)
• Abstract body (maximum 300 words, including the following sections)
• Objectives: At least 2 clear and measurable objectives
• Background: A brief statement on why the study was conducted
• Methods: The methods of study or experimental approach must be briefly defined
• Results: A summary of the study results, including sufficient detail to support the conclusions
• Conclusions: A statement explaining the significance of the study and its implications for further research
• Authors (maximum 11): Include full names with institution and country
• Preferred Presentation Type: You may indicate your preferred presentation type– Oral or E-Poster – but the Abstract Selection Committee will make the final format determination
• Disclose conflict of interest and accept terms and conditions

Editing

Abstracts may be edited until the submission deadline. After that, no changes in content or co-authors may be made. Once the review process begins, no changes to submissions are allowed – no exceptions

Please note that any typographical or spelling errors, improperly formatted titles, etc., WILL NOT be edited by anyone at the Organizing Committee. It is the responsibility of the Submitting Author to review and verify all work submitted

Deadline for abstract submission is June 28, 2025 at 12PM local time

In case you want to withdraw your abstract after submission, please send an email before 1st, July 2025 to icran2025@pharma-pro.com